Phio Pharmaceuticals
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2012-01-01
- Employees
- 9
- Market Cap
- $2.7M
- Website
- http://www.phiopharma.com
- Introduction
Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.
Phio Pharmaceuticals' PH-762 Shows Complete Tumor Clearance in Skin Cancer Trial
Phio Pharmaceuticals reports two patients with cutaneous squamous cell carcinoma achieved complete tumor clearance in a Phase 1b trial of PH-762.
Phio Pharmaceuticals Completes Enrollment in Phase 1b Trial of PH-762 for Skin Cancers
Phio Pharmaceuticals has completed enrollment in the second cohort of its Phase 1b dose-escalating clinical trial of PH-762.
Phio Pharmaceuticals' INTASYL Platform Enhances Immune Cell Targeting of Cancer
Phio Pharmaceuticals announced data showcasing its INTASYL siRNA technology's ability to enhance immune cell targeting and killing of cancer cells.